Multi-millionaire businessman, 48, who launched into space with William Shatner on Jeff Bezos' Blue Origin rocket last month dies in NJ plane crash
- Glen de Vries, 49, who flew into space with William Shatner last month died in a plane crash in Sussex County, New Jersey on Thursday
- He was flying in a small, single engine plane with Thomas Fischer, 54, of Fischer Aviation when the plane went down around 3 p.m.
- Police and the FAA are currently investigating why the plane crashed
- Vries made his fortune through Medidata Solutions, which has managed more than 25,000 clinical trials involving more than seven million patients
https://www.dailymail.co.uk/news/article-10196333/Businessman-went-space-William-Shatner-dies-New-Jersey-plane-crash.html
Glen de Vries (June 29, 1972 – November 11, 2021) was an American businessman and co-founder and co-CEO of Medidata Solutions and a space tourist.[1]
De Vries grew up in New York and showed a passion for computers at a young age. His mother encouraged him to learn to dance in high school.[2] De Vries attended Carnegie Mellon University and graduated in 1994. He taught himself to speak Japanese.[3]
Blue Origin flight
On October 13, 2021, de Vries accompanied William Shatner along with two other astronauts on a New Shepard rocket as part of the Blue Origin NS-18 mission into space.[4][5]
Death
De Vries died in an airplane crash in Hampton Township,Sussex County, New Jersey on November 11, 2021. He was a certified private pilot with an instrument rating.[6][7]
カーネギーメロン大学と言えばとまべっち。
とまべっち＠天台宗と言えば瀬戸内寂聴（★）＠天台宗。
瀬戸内寂聴と言えば小保方さん・・・
https://tokumei10.blogspot.com/2021/11/remember.html
→Fake Medical Trials
必死にイスカリオテしてたとまべっち逃げてええ！全力で走って逃げてええ！（爆ｗｗｗｗｗｗｗ
Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. Headquartered in New York City, Medidata has locations in China, Japan, Singapore, South Korea, the United Kingdom, and the United States.
Medidata's customers include pharmaceutical, biotechnology, medical device, and diagnostic companies; academic and government institutions; contract research organizations; and other life sciences organizations around the world that develop and bring medical therapies and products to market.
The company was founded in June 1999 by Tarek Sherif, Glen de Vries and Ed Ikeguchi.[4][5][6] In 1994, de Vries and Ikeguchi created OceanTek, a startup that developed Web applications for conducting clinical trials and was the precursor to Medidata.[7] In 1999, they restarted the company as a new firm and, together with Sherif, formed Medidata, to provide online systems for designing and running clinical trials.[7][8] In 2004, they completed a $10 million round of financing with Insight Venture Partners,[8] and were later backed by investors including Milestone Venture Partners and Stonehenge Capital Fund.[9] Ikeguchi left the company in 2008, and de Vries moved from chief technology officer to president, with Tarek as chief executive officer.[7]
On January 26, 2009, Medidata filed to raise $86 million in an initial public offering (IPO).[9] It made its IPO on the Nasdaq Stock Market on June 25, 2009, with its market capitalization at $313 million.[10] It debuted on the Nasdaq at $18 per share.[5] The company was ranked #11 on Fortune magazine's 2017 Fortune Future 50 list,[11]#51 on the Fortune 100 Fastest Growing Companies list,[12] and #59 on the Forbes list of Most Innovative Growth Companies, at a value of $3.3 billion as of May 2017.[13] In 2018, Medidata was ranked #70 on Barron's 100 Most Sustainable Companies list.[14]
In December 2019, Medidata was acquired by Dassault Systèmes.[15] Medidata now functions as a subsidiary.[16]
Edward Ikeguchi, MD
Dr. Edward Ikeguchi is one of the founders of Medidata Solutions, an electronic clinical data management company, where he works as the Chief Medical Officer. Dr. Ikeguchi graduated Phi Beta Kappa in Chemistry from Fordham University and then received his medical degree at Columbia University College of Physicians and Surgeons in 1992. He subsequently completed his surgical internship, urology residency, and fellowship training at Columbia-Presbyterian Medical Center in New York City.Despite Dr Ikeguchi’s talents as a surgeon, his interests have always extended beyond clinical medicine. In 1984, he was a member of the Gold Medal winning U.S. Olympic Shooting Team in Los Angeles, California. He is also a published author.
Following his training, Dr. Ikeguchi remained at Columbia University as an Assistant Professor of Urology, working in a combination of clinical and research capacities. He engineered several patented medical devices that have gone through the clinical development process. He also served as a clinical investigator in numerous trials sponsored by the pharmaceutical industry and the NIH. This experience in technology-based applications and clinical trials related to the pharmaceutical and biotechnology industries expanded his expertise in regulatory processes and compliance.
Dr. Ikeguchi was among a group of researchers and scientists from Columbia University who observed the limitations of data capture tools available for clinical trials work. In 1999, Dr Ikeguchi joined Tarek Sherif and Glen de Vries to develop Medidata Solutions, a privately held New York City based company, with the goal of creating a powerful but user-friendly electronic data capture system for clinical trial use that would improve productivity and workflow.
Medidata Solutions has rapidly become a leading provider of web-based data management solutions for clinical trials, streamlining the process of collecting, verifying, and consolidating research data. The company’s products and services are designed for front-line clinical research, giving sponsors, investigators, monitors and data managers the earliest possible visibility into data. Better decision-making, improved resource allocation, and better science are the company’s goals. Medidata Solutions has recently expanded operations into Europe and Asia.
https://prnresource.com/profiles/edward-ikegichi-md
2021年11月13日土曜日
少しでも統計学が理解できる香具師ならコレは絶対に接種したらあかん奴やと分かるわけだが・・・
2021年11月3日水曜日
コロナワクチンの治験での協力会社Ventavia Research Groupのデータ改ざん不正発覚でファイザー社の免疫力が急激に低下
- Fort Worth, Texas, United StatesStudy Start Up SpecialistVentavia Research GroupEDC,, use of systems such as Medidata Rave Identifying AE's and SAE's ... Strategic Business Operations Lead at Ventavia Research Group. Fort Worth, TX ...
Job Finder | Careers | CareerOneStop
Global Clinical Trials Effective Implementation and Management
確定ですな。さあ大変だ！（爆ｗｗｗｗｗｗｗｗｗｗｗｗ
3 件のコメント:
時かけ方面や宇宙xx方面全滅とかなっちゃいますかねぇ…
ガチに
俺たちの苫米地
全力で逃げろ案件
って分かる感じが(苦
ガチにワクチン接種者
救えなくなったから
その健康と命をね
KEI & MAKO も 大気圏突入（爆）
コメントを投稿